Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sellas Life Sciences disclosed preclinical pancreatic cancer data for SLS009, a CDK9 inhibitor, from patient-derived organoid studies. Results are being presented at the AACR Conference on Pancreatic Cancer, running Sept. 25-28, 2026, in San Diego. SLS009 showed stronger single-agent anti-tumor activity than a RAS inhi
Vivesto flagged newly reported topline results from two Paccal Vet studies for presentation at the Veterinary Cancer Society conference on Sept. 24. Dog pilot study in splenic hemangiosarcoma showed supportive survival and safety outcomes, reinforcing the case to move into a pivotal trial. Cat dose-escalation study ind
Agenus announces three-year survival data from Phase 1b BOT+BAL study in MSS metastatic colorectal cancer to be presented at ESMO GI 2026